A number of studies using radiology procedures against obesity were presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting. The event took place recently in San Francisco, California.
Obesity represents one of the main health issues in a lot of communities. For instance, the Centers for Disease Control and Prevention in the US say that nearly 127 million (65%) citizens in the country are currently being overweight, obese or morbidly obese. In addition, the morbidity rate of obesity in the US is rising.
During the Society of Interventional Radiology's 37th Annual Scientific Meeting, several studies about using radiology against obesity were discussed. For instance, one of the studies used minimally invasive X-ray on the arteries of the stomach to block hunger feeling. Another study discussed the use of stem cells in cases of vertebral disc degeneration.
Charles Y. Kim, M.D., assistant professor of radiology at Duke University Medical Center in Durham, N.C., and a lead author in the studies, said "Currently, there are three clinically viable surgical alternatives for obesity: gastric bypass surgery, gastric pacing and endoscopic gastric banding. These procedures have varying success rates; they are invasive, require extensive gastric/bowel reconstruction or external devices and can have significant surgical complications."
Dr. Kim continued "Our promising results led us to believe that a minimally invasive interventional radiology treatment - called bariatric arterial embolization - would allow for precise targeting of a specific portion of a person's stomach in order to decrease production of ghrelin, a hormone that causes hunger. This treatment could one day be the answer for those who have not been successful with weight loss through diet and exercise."
The new minimally invasive procedure is “Embolization”. The latter is carried out by an interventional radiologist as he injects small particles of certain substance into a thin catheter. These particles go to arteries that supply specific regions in the stomach, and then the arteries are blocked.
Dr. Kim said "Interventional radiologists have safely and effectively used embolization in many other disease states for decades. For this study, we selectively blocked and decreased the blood flow to a very specific part of the stomach using specialized radiologic equipment, which led to significantly decreased levels of ghrelin in the animals that we treated.”
He continued “We found that when ghrelin levels decrease, appetite and hunger also decrease, causing weight loss in the treated animals relative to non-treated animals. Bariatric arterial embolization may have a future use in treating obesity in humans by significantly suppressing appetite to achieve weight loss."
In regards to the second study, a research team assessed a new type of embolic bead which is visible in X-rays in bariatric arterial embolization. The team was led by
Clifford R. Weiss, M.D., assistant professor of radiology at Johns Hopkins University, School of Medicine in Baltimore, Md.
Dr. Weiss said: "Until now, clinically available embolic beads have not been visible on X-ray during or after delivery. We developed a new embolic bead that can be seen directly by X-ray imaging and have tested them in the new bariatric embolization treatment for obesity. The current system requires that the beads be mixed with X-ray-visible contrast agents before delivery. Although this mixture is visible during infusion, the contrast immediately washes away, and the location of the beads can no longer be 'tracked'.”
He continued “By making the beads X-ray visible and using them in tandem with C-arm cone-beam CT - a new way of X-ray imaging that creates 3-D pictures - these beads can be tracked both during and after delivery. This allows for more precise assessment of 'on-target' embolization. Due to the fact that these beads are visible and can be tracked over time, we should be able to assess their long-term presence. If needed, the patient can then be retreated."
Dr. Weiss added "With the current clinically available beads, it is not possible to determine whether they are intact and functional over time. We recommend further studies to prove the beads' safety over time and ensure they do not have any unintended effects on the target organs or on the individuals being treated. We believe there are myriad possible applications for these beads, such as treating cancer of the liver or non-cancerous uterine masses."
In another study, a research team injected stem cells in animals using only a needle while depending on X-ray guidance. This procedure can help in treating degenerated intervertebral discs, which is a very painful condition.
J. David Prologo, M.D., an interventional radiologist at University Hospitals Case Medical Center in Cleveland, Ohio, said "Even though 80 percent of people will have painful degenerated discs by age 65 and degenerated intervertebral discs are a significant contributor to low back pain, effective therapies are lacking. The current treatment is surgical removal of these damaged discs, and this often requires more than one surgical procedure.”
Dr. Prologo added "Interventional radiologists acted on a need for a minimally invasive treatment that could mean faster recovery and less need for repeat surgeries in individuals suffering from debilitating disc disease."
He continued "Stem cell therapies are increasingly showing great promise for disc regeneration and biological repair and may represent a promising alternative to destroying the disc, replacement or immobilization.”
He explained “All adults have stem cells that can be isolated from their bone marrow, and we observed that repair could be achieved by injecting a person's own stem cells into the bad discs. After attaching an imaging agent to the injected cells, we were able to prove accurate delivery and containment of those cells at the desired site of action. And, we are now performing the first in human trials of this technique."